COVID-19

Featured

Blood thickness is emerging as an important indicator of dangerous complications in Covid-19 patients, causing demand for blood viscometers.  
Vienna, August 5, 2020 — A laboratory test that has now been developed by a study group from MedUni Vienna is able to determine whether COVID-19 patients develop protective antibodies after having the disease.
Kelly Airey, MD, FHRS, FACC shares her experience managing cases at Cardiovascular Medicine, P.C. and Genesis Health System during the COVID-19 pandemic.
EP Lab Digest talks with Tracy Kane Lofty, MSA, CAE and Charles J. Love, MD about the changes being made in certification testing by the International Board of Heart Rhythm Examiners (IBHRE) amid the COVID-19 pandemic.
Sheharyar Minhas, MD et al present a case describing the presence of high-grade AV block requiring pacemaker support in a patient with COVID-19
June 25, 2020 — A persistent cough and fever have been confirmed as the most prevalent symptoms associated with COVID-19, according to a major review of the scientific literature. Other major symptoms include fatigue, losing the ability to smell
Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a study from researchers at Johns
June 15, 2020 — A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus that causes the disease, when tested in animals and human cell